38681227|t|Unraveling potential neuroprotective mechanisms of herbal medicine for Alzheimer's diseases through comprehensive molecular docking analyses.
38681227|a|Alzheimer's disease (AD) continues to be a worldwide health concern, demanding innovative therapeutic approaches. This study investigates the neuroprotective potential of herbal compounds by scrutinizing their interactions with Beta-Secretase-1 (BACE1). Through comprehensive molecular docking analyses, three compounds, Masticadienonic acid (DeltaG: -9.6 kcal/mol), Hederagenin (DeltaG: -9.3 kcal/mol), and Anthocyanins (DeltaG: -8.1 kcal/mol), emerge as promising BACE1 ligands, displaying low binding energies and strong affinities. ADME parameter predictions, drug-likeness assessments, and toxicity analyses reveal favorable pharmacokinetic profiles for these compounds. Notably, Masticadienonic Acid exhibits optimal drug-likeness (-3.3736) and negligible toxicity concerns. Hederagenin (drug-likeness: -5.3272) and Anthocyanins (drug-likeness: -6.2041) also demonstrate promising safety profiles. Furthermore, pharmacophore modeling elucidates the compounds' unique interaction landscapes within BACE1's active site. Masticadienonic acid showcases seven hydrophobic interactions and a hydrogen bond acceptor interaction with Thr232. Hederagenin exhibits a specific hydrogen bond acceptor interaction with Trp76, emphasizing its selective binding. Anthocyanins reveal a multifaceted engagement, combining hydrophobic contacts and hydrogen bond interactions with key residues. In conclusion, Masticadienonic acid, Hederagenin, and Anthocyanins stand out as promising candidates for further experimental validation, presenting a synergistic balance of efficacy and safety in combating AD through BACE1 inhibition.
38681227	71	91	Alzheimer's diseases	Disease	MESH:D000544
38681227	142	161	Alzheimer's disease	Disease	MESH:D000544
38681227	163	165	AD	Disease	MESH:D000544
38681227	370	386	Beta-Secretase-1	Gene	23621
38681227	388	393	BACE1	Gene	23621
38681227	463	483	Masticadienonic acid	Chemical	MESH:C459620
38681227	509	520	Hederagenin	Chemical	MESH:C025763
38681227	550	562	Anthocyanins	Chemical	MESH:D000872
38681227	608	613	BACE1	Gene	23621
38681227	737	745	toxicity	Disease	MESH:D064420
38681227	827	847	Masticadienonic Acid	Chemical	MESH:C459620
38681227	904	912	toxicity	Disease	MESH:D064420
38681227	923	934	Hederagenin	Chemical	MESH:C025763
38681227	964	976	Anthocyanins	Chemical	MESH:D000872
38681227	1145	1150	BACE1	Gene	23621
38681227	1166	1186	Masticadienonic acid	Chemical	MESH:C459620
38681227	1396	1408	Anthocyanins	Chemical	MESH:D000872
38681227	1539	1559	Masticadienonic acid	Chemical	MESH:C459620
38681227	1561	1572	Hederagenin	Chemical	MESH:C025763
38681227	1578	1590	Anthocyanins	Chemical	MESH:D000872
38681227	1731	1733	AD	Disease	MESH:D000544
38681227	1742	1747	BACE1	Gene	23621
38681227	Association	MESH:D000544	23621
38681227	Negative_Correlation	MESH:C459620	MESH:D000544
38681227	Negative_Correlation	MESH:C025763	23621
38681227	Negative_Correlation	MESH:D000872	MESH:D000544
38681227	Negative_Correlation	MESH:C459620	23621
38681227	Negative_Correlation	MESH:D000872	23621
38681227	Negative_Correlation	MESH:C025763	MESH:D000544

